The USDJPY pair rose as much as 2% early in the session after the Bank of Japan did not change its monetary policy, even though 10-year bond yields exceeded the target. Today, however, we are witnessing a powerful blow to the dollar that was sparked by the release of 3 important macroeconomic figures:
-
PPI inflation falls to 6.2% y/y and is lower than CPI inflation
-
Retail sales dropped by 1.1% m/m for December and this is another month of decline (the last two months of the year are usually strong in terms of retail sales)
-
Industrial production fell to -0.7% m/m, which is the third month of declines in a row (is is worth remembering that the US ISM Manufacturing PMI fell to 48.4 in December, pointing to the 2nd month of contraction in factory activity)
This picture shows that the economy has actually cooled down, with only the labor market remaining strong, especially in the service sector. Nevertheless, one needs to remember that a possible strong slowdown or even a recession may bring huge layoffs in the service sector, as it was in the initial phase of the pandemic. Weak data may be an important factor for the Fed when making its next monetary policy decision in February. If the Fed announces its readiness to end rate hikes sooner or will refrain from further balance sheet reduction, it would be great news for equities and negative for the US dollar.
USDJPY - the dollar fell sharply after today;s data releases and weakens even against the yen. If today's D1 candle will close at the current levels, then this will create a potential bearish signal. US bond yields are at their lowest since September and USDJPY is heading towards support 127.00. which coincides with a 50.0% Fibonacci retracement. A break below this level could push the pair towards the 125.00 mark. Source: xStation5
Chart of the Day: EURUSD Higher, but Still a Game of Expectations, Not a Trend
NOK surges following Norges Bank's rate hike
BREAKING: Strong data from the German manufacturing sector!
Morning Wrap: US–Iran Peace Talks in the Shadow of Trump’s Ultimatum
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.